Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

Clinical trial NCT02509312 · COMPLETED

Trial details

NCT number: NCT02509312
Sponsor: University Hospitals Cleveland Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Analgesia, Obstetrical Postpartum Hemorrhage Opioid Use Nonsteroidals (NSAIDs)Toxicity Coagulation Defect; Postpartum Postoperative Pain Ketorolac Adverse Reaction Blood Loss, Postoperative

Start date: 2016-05-01
Primary completion: 2017-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.